148 related articles for article (PubMed ID: 22422299)
1. The use of the microplate alamar blue assay (MABA) to assess the susceptibility of Mycobacterium lepraemurium to anti-leprosy and other drugs.
Mendoza-Aguilar M; Almaguer-Villagrán L; Jiménez-Arellanes A; Arce-Paredes P; Cid-Gutiérrez JL; Rojas-Espinosa O
J Infect Chemother; 2012 Oct; 18(5):652-61. PubMed ID: 22422299
[TBL] [Abstract][Full Text] [Related]
2. Effect of reactive oxygen intermediaries on the viability and infectivity of Mycobacterium lepraemurium.
Wek-Rodriguez K; Silva-Miranda M; Arce-Paredes P; Rojas-Espinosa O
Int J Exp Pathol; 2007 Jun; 88(3):137-45. PubMed ID: 17504443
[TBL] [Abstract][Full Text] [Related]
3. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium.
Collins L; Franzblau SG
Antimicrob Agents Chemother; 1997 May; 41(5):1004-9. PubMed ID: 9145860
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of microplate Alamar blue assay for drug susceptibility testing of Mycobacterium avium complex isolates.
Vanitha JD; Paramasivan CN
Diagn Microbiol Infect Dis; 2004 Jul; 49(3):179-82. PubMed ID: 15246507
[TBL] [Abstract][Full Text] [Related]
5. Microplate nitrate reductase assay versus Alamar Blue assay for MIC determination of Mycobacterium tuberculosis.
Kumar M; Khan IA; Verma V; Qazi GN
Int J Tuberc Lung Dis; 2005 Aug; 9(8):939-41. PubMed ID: 16104645
[TBL] [Abstract][Full Text] [Related]
6. A rapid, microplate-based assay for evaluating the activity of drugs against Mycobacterium leprae, employing the reduction of Alamar Blue.
Franzblau S
Lepr Rev; 2000 Dec; 71 Suppl():S74-5; discussion S76. PubMed ID: 11201892
[No Abstract] [Full Text] [Related]
7. Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein.
Hartkoorn RC; Chandler B; Owen A; Ward SA; Bertel Squire S; Back DJ; Khoo SH
Tuberculosis (Edinb); 2007 May; 87(3):248-55. PubMed ID: 17258938
[TBL] [Abstract][Full Text] [Related]
8. A radiometric method for predicting effectiveness of chemotherapeutic agents in murine leprosy.
Camargo EE; Larson SM; Tepper BS; Wagner HN
Int J Lepr Other Mycobact Dis; 1975; 43(3):234-8. PubMed ID: 176120
[TBL] [Abstract][Full Text] [Related]
9.
Silva-Miranda M; Arce-Paredes P; Rojas-Espinosa O
Int J Mycobacteriol; 2017; 6(1):52-60. PubMed ID: 28317806
[TBL] [Abstract][Full Text] [Related]
10. Induction and treatment of anergy in murine leprosy.
Juarez-Ortega M; Hernandez VG; Arce-Paredes P; Villanueva EB; Aguilar-Santelises M; Rojas-Espinosa O
Int J Exp Pathol; 2015 Feb; 96(1):31-41. PubMed ID: 25529580
[TBL] [Abstract][Full Text] [Related]
11. In vitro sensitivity of Mycobacterium lepraemurium for antimycobacterial drugs.
Portaels F; Pattyn SR; Francken A
Arzneimittelforschung; 1982; 32(9):1123-4. PubMed ID: 6756417
[TBL] [Abstract][Full Text] [Related]
12. Contrary to BCG, MLM fails to induce the production of TNF alpha and NO by macrophages.
Rojas-Espinosa O; Wek-Rodríguez K; Arce-Paredes P; Aguilar-Torrentera F; Truyens C; Carlier Y
Int J Lepr Other Mycobact Dis; 2002 Jun; 70(2):111-8. PubMed ID: 12211895
[TBL] [Abstract][Full Text] [Related]
13. Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis.
Taneja NK; Tyagi JS
J Antimicrob Chemother; 2007 Aug; 60(2):288-93. PubMed ID: 17586560
[TBL] [Abstract][Full Text] [Related]
14. Antimycobacterial activities of two newer ansamycins, R-76-1 and DL 473.
Ji BH; Chen JK; Lu XZ; Wang SY; Ni GX; Hou YH; Zhou DH; Tang QK
Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):563-77. PubMed ID: 3546547
[TBL] [Abstract][Full Text] [Related]
15. Restored pathogenicity of attenuated Mycobacterium lepraemurium in mice.
Nomaguchi H; Kohsaka K; Miyata Y; Mori T; Ito T
Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):446-52. PubMed ID: 3528347
[TBL] [Abstract][Full Text] [Related]
16. Activated murine natural killer cells control growth of Mycobacterium lepraemurium in mouse macrophages; in vitro and in vivo evidence.
Denis M
Int J Immunopharmacol; 1991; 13(7):881-7. PubMed ID: 1761354
[TBL] [Abstract][Full Text] [Related]
17. Immune response in BALB/c mice following immunization with heat-killed Mycobacterium lepraemurium.
Graham L; Navalkar RG
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):121-8. PubMed ID: 6380152
[TBL] [Abstract][Full Text] [Related]
18. Strain differences in mouse cellular responses to Mycobacterium lepraemurium and BCG subcutaneous infections. I. Analysis of cell surface phenotype in local granulomas.
Roch F; Bach MA
Clin Exp Immunol; 1990 Jun; 80(3):332-8. PubMed ID: 2197047
[TBL] [Abstract][Full Text] [Related]
19. Influence of route of inoculation on anti-Mycobacterium lepraemurium antibody isotypes in murine leprosy.
Hoffenbach A; Diioro L; Bach MA
Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):305-15. PubMed ID: 3298477
[TBL] [Abstract][Full Text] [Related]
20. Lack of a sustained protection against murine leprosy in C3H mice vaccinated with extracts of Mycobacterium lepraemurium in admixture with Mycobacterium bovis (BCG).
Turcotte R; Lemieux S
Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):494-500. PubMed ID: 6763006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
